Tranexamic Acid in Traumatic Brain Injury
ConditionInflammatory Response
Trial statusRecruiting
Trial phasePhase 3
Trial typeInterventional
Biological sexAll
Age18-65
SponsorAssiut University
About this trial
In this study, our aim is to investigate the role of tranexamic acid for modulating the inflammation in patients with traumatic brain injury (TBI).
Eligibility criteria
Qualifiers
Isolated traumatic brain injury patients (mild or moderate cases)
GCS > 8
non penetrating TBI in 8 hours onset
Age ≥ 18 years
Disqualifiers
Patient in cardiac arrest
Patients with coagulopathies
Renal failure patients
pregnancy
Trial design
Treatments tested in this trial
- Saline
- Tranexamic acid
Treatment groups
60 Participants
are divided into 2 treatment groupsSponsors and collaborators
Source ClinicalTrials.gov